Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,717 | -6,834 | -17,411 | -11,508 | -5,175 |
| Depreciation Amortization | 197 | 106 | 567 | 451 | 328 |
| Accounts payable and accrued liabilities | -1,805 | -926 | 518 | 129 | 205 |
| Other Working Capital | -1,276 | -642 | 2,911 | 2,735 | 3,220 |
| Other Operating Activity | 2,797 | 1,645 | 1,685 | 1,716 | 1,185 |
| Operating Cash Flow | $-12,804 | $-6,651 | $-11,730 | $-6,477 | $-237 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -3,467 | -3,467 | -3,467 |
| Common Stock Issued | 3,970 | N/A | 9,475 | 6,427 | 2,083 |
| Other Financing Activity | -4 | -3 | -10 | -8 | -8 |
| Financing Cash Flow | $3,966 | $-3 | $5,998 | $2,952 | $-1,392 |
| Beginning Cash Position | 16,904 | 16,904 | 22,636 | 22,635 | 22,635 |
| End Cash Position | 8,066 | 10,250 | 16,904 | 19,110 | 21,006 |
| Net Cash Flow | $-8,838 | $-6,654 | $-5,732 | $-3,525 | $-1,629 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,804 | -6,651 | -11,730 | -6,477 | -237 |
| Free Cash Flow | -12,804 | -6,651 | -11,730 | -6,477 | -237 |